Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript
Source: SeekingAlpha
2025-10-28 18:21:51 ET
Innate Pharma S.A. (IPHA) Analyst/Investor Day October 28, 2025 8:00 AM EDT
Company Participants
Jonathan Dickinson - CEO & Director
Sonia Quaratino - Executive VP & Chief Medical Officer
Stéphanie Cornen
Stephanie Cornen - Vice President of Investor Relations, Communication & Commercial Strategy
Yannis Morel - Executive VP & COO
...
Read the full article on Seeking Alpha
For further details see:
Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript
Innate Pharma - Class A
NASDAQ: IPHYF
IPHYF Trading
-63.76% G/L:
$2.155 Last:
100 Volume:
$2.155 Open:
IPHYF Latest News
February 19, 2026 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
February 18, 2026 01:00:00 am
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
December 22, 2025 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
IPHYF Stock Data
$160,353,438
44,923,628
N/A
20
N/A
Biotechnology & Life Sciences
Healthcare
FR
Marseille
